1-2 of 2
Keywords: OnabotulinumtoxinA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Botulinum Toxin A in Clinical Practice, the Technical Aspects and What Urologists Want to Know about It

Available to Purchase
Subject Area:
Further Areas
Hendrikje M.K. van Breda, John P.F.A. Heesakkers
Journal: Urologia Internationalis
Urol Int (2015) 95 (4): 411–416.
https://doi.org/10.1159/000381881
Published Online: 13 May 2015
... like training in practical aspects. Conclusions: No firm data exist about the technique of application with consequently the most optimal results. BTA treatment is regarded as an easy-to-learn, but still there is a request for training in practical treatment aspects. OnabotulinumtoxinA Botulinum...
View article titled, Botulinum Toxin A in Clinical Practice, the Technical Aspects and What Urologists Want to Know about It
Open the PDF for Botulinum Toxin A in Clinical Practice, the Technical Aspects and What Urologists Want to Know about It in another window
Journal Articles

Submucosal Administration of OnabotulinumtoxinA in the Treatment of Neurogenic Detrusor Overactivity: Pilot Single-Centre Experience and Comparison with Standard Injection into the Detrusor

Available to Purchase
Subject Area:
Further Areas
Vladimír Šámal, Jan Mečl, Jaroslav Šrám
Journal: Urologia Internationalis
Urol Int (2013) 91 (4): 423–428.
https://doi.org/10.1159/000350247
Published Online: 14 June 2013
..., randomised, prospective study was performed on a total of 23 patients with neurogenic detrusor overactivity. Following randomisation, patients were treated with 300 U of onabotulinumtoxinA (onaBoNT/A) in either the submucosa or the detrusor. Urodynamic examinations were carried out, and a bladder diary...
View article titled, Submucosal Administration of OnabotulinumtoxinA in the Treatment of Neurogenic Detrusor Overactivity: Pilot Single-Centre Experience and Comparison with Standard Injection into the Detrusor
Open the PDF for Submucosal Administration of OnabotulinumtoxinA in the Treatment of Neurogenic Detrusor Overactivity: Pilot Single-Centre Experience and Comparison with Standard Injection into the Detrusor in another window